Advancing Pulmonary Arterial Hypertension Therapy through Encapsulated Mini Tablets: A Dual-Release Strategy for Bosentan and Sildenafil Citrate

Pulmonary Arterial Hypertension (PAH) remains a formidable challenge in cardiovascular therapeutics. Despite numerous pharmacological advances, the disease demands innovative strategies that address both patient compliance and long-term efficacy. This article explores a novel formulation concept—encapsulated mini tablets (MTs)—combining immediate-release Sildenafil…